Trial intelligence / Profile preview

Efficacy of melatonin on nocturnal irritability

IRCT20090808002306N8Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of melatonin, sponsored by Isfahan University of Medical Sciences. Started Dec 2022; status: completed.

02

Drugs

melatonin

Beyond the preview

Go deeper on IRCT20090808002306N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20090808002306N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call